Correction to: Oncogene (2014) 34, 838–845; doi:10.1038/onc.2014.20; published online 10 March 2014
Since the publication of the above article the authors have noted an error in Figure 5b.
In the figure, the ‘structure’ of N389 is shown as ‘(iv)’ and that of N420 as ‘(i)’, but in actuality the reverse is true. Namely, the ‘structure’ of N389 is ‘(i)’ and that of N420 is ‘(iv)’. As such, accurately depicted, the table should appear as shown in Figure 5.
Although these errors do not affect the conclusion of the paper the authors apologise for any inconvenience caused.
The online version of the original article can be found at 10.1038/onc.2014.20
About this article
Cite this article
Hasegawa, Y., Takahashi, M., Ariki, S. et al. Erratum: Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signalling. Oncogene 34, 4285–4286 (2015). https://doi.org/10.1038/onc.2015.266
The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity
MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma
Artificial Cells, Nanomedicine, and Biotechnology (2019)
Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β
Frontiers in Immunology (2018)
Chemical Communications (2018)